Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tae Hyun Kang

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Experimental & Molecular Medicine|November 19, 2019
Boosting therapeutic potency of antibodies by taming Fc domain functionsTae Hyun Kang, Sang Taek Jung
Biomolecules|March 4, 2020
Reprogramming the Constant Region of Immunoglobulin G Subclasses for Enhanced Therapeutic Potency against CancerTae Hyun Kang, Sang Taek Jung
Frontiers in Microbiology|October 26, 2020
Solubility, Stability, and Avidity of Recombinant Antibody Fragments Expressed in MicroorganismsTae Hyun Kang, Baik Lin Seong
Micromachines|November 9, 2018
Farewell to Animal Testing: Innovations on Human Intestinal Microphysiological SystemsTae Hyun Kang, Hyun Jung Kim
Biotechnology and Bioengineering|May 28, 2010
Efficient expression and purification of human aglycosylated Fcgamma receptors in Escherichia coliSang Taek Jung, Tae Hyun Kang, George Georgiou
Metabolic Engineering|December 7, 2010
Comprehensive engineering of Escherichia coli for enhanced expression of IgG antibodiesTomohiro Makino, Georgios Skretas, Tae-Hyun Kang, et al.
Current Opinion in Biotechnology|March 23, 2011
Bypassing glycosylation: engineering aglycosylated full-length IgG antibodies for human therapySang Taek Jung, Tae Hyun Kang, William Kelton, et al.
ACS Chemical Biology|July 4, 2012
Revisiting the role of glycosylation in the structure of human IgG FcM Jack Borrok, Sang Taek Jung, Tae Hyun Kang, et al.
International Journal of Molecular Sciences|September 10, 2021
Fc Receptor Variants and Disease: A Crucial Factor to Consider in the Antibody Therapeutics in ClinicJin Kim, Ji Young Lee, Han Gil Kim, et al.
Protein Science : a Publication of the Protein Society|November 24, 2022
A robust antibody discovery platform for difficult-to-express G protein-coupled receptorsNam Hyuk Kim, Sumin Kang, Ga Hyeon Park, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Experimental & Molecular Medicine|November 19, 2019
Boosting therapeutic potency of antibodies by taming Fc domain functionsTae Hyun Kang, Sang Taek Jung
Biomolecules|March 4, 2020
Reprogramming the Constant Region of Immunoglobulin G Subclasses for Enhanced Therapeutic Potency against CancerTae Hyun Kang, Sang Taek Jung
Frontiers in Microbiology|October 26, 2020
Solubility, Stability, and Avidity of Recombinant Antibody Fragments Expressed in MicroorganismsTae Hyun Kang, Baik Lin Seong
Micromachines|November 9, 2018
Farewell to Animal Testing: Innovations on Human Intestinal Microphysiological SystemsTae Hyun Kang, Hyun Jung Kim
Biotechnology and Bioengineering|May 28, 2010
Efficient expression and purification of human aglycosylated Fcgamma receptors in Escherichia coliSang Taek Jung, Tae Hyun Kang, George Georgiou
Metabolic Engineering|December 7, 2010
Comprehensive engineering of Escherichia coli for enhanced expression of IgG antibodiesTomohiro Makino, Georgios Skretas, Tae-Hyun Kang, et al.
Current Opinion in Biotechnology|March 23, 2011
Bypassing glycosylation: engineering aglycosylated full-length IgG antibodies for human therapySang Taek Jung, Tae Hyun Kang, William Kelton, et al.
ACS Chemical Biology|July 4, 2012
Revisiting the role of glycosylation in the structure of human IgG FcM Jack Borrok, Sang Taek Jung, Tae Hyun Kang, et al.
International Journal of Molecular Sciences|September 10, 2021
Fc Receptor Variants and Disease: A Crucial Factor to Consider in the Antibody Therapeutics in ClinicJin Kim, Ji Young Lee, Han Gil Kim, et al.
Protein Science : a Publication of the Protein Society|November 24, 2022
A robust antibody discovery platform for difficult-to-express G protein-coupled receptorsNam Hyuk Kim, Sumin Kang, Ga Hyeon Park, et al.
Pageof 3